Hypoguard Sponsors First-Of-Its-Kind Education Program In Diabetes Management

EDINA, Minn., March 1 /PRNewswire/ -- Hypoguard USA, Inc., a leading manufacturer of diagnostic products and related medical devices for a range of chronic conditions, is offering its customers the first and only specialized continuing education program for managing diabetes. Designed especially for nurses and nursing assistants in long-term care facilities, the program is made possible through an unrestricted educational grant from Hypoguard.

“As the leader in diabetes management products and services for the long- term care market, Hypoguard has a pulse on the needs of professionals who care for patients with this chronic condition,” said David Conn, Hypoguard’s chief executive officer. “Hypoguard is pleased to sponsor this important program.”

The video-based program provides valuable insights and information to help nurses and other healthcare professionals understand the key areas of assessment, clinical goals and variables involved in the evaluation and management of patients with diabetes in long-term care facilities.

Expert training with available certification

The training course describes diabetic testing equipment within the overall framework of the evaluation and treatment of diabetes among the geriatric population. Participants in the Hypoguard-sponsored program will receive 1.0 contact hours of continuing nursing education. Program is offered through January 20, 2006. There are no prerequisites for the program, and certification will be available to licensed practical nurses, registered nurses, nurse managers and other healthcare professionals primarily working in long-term care facilities.

The 51-minute videotape presentation is produced by MedCentrus, a division of Juntunen Group, a healthcare communication and education company based in Minneapolis. The organization delivers custom communications and training solutions to medical device, pharmaceutical companies and healthcare organizations.

About Hypoguard

Hypoguard ( http://www.hypoguard.com/ ) is a leading healthcare company specializing in diagnostic products and medical products at the point of care. Hypoguard designs, develops, manufactures and markets diagnostic products and related medical devices used to monitor chronic conditions such as diabetes. The company’s primary products include a broad line of blood glucose monitoring systems, safety lancets and lancing devices, as well as urine testing equipment and supplies.

Hypoguard USA, Inc.

CONTACT: Kristin Seigworth of Seroka Public Relations, +1-262-523-3740,kristin@seroka.com